← Markets

Goosehead Insurance, Inc

GSHD · NASDAQ

Market closed$54.28$-0.890000 (-1.61%)After hours $54.28 · 0.00%

Key statistics

Previous close$55.17
Open$57.17
Day high$57.38
Day low$54.09
52-week high$104.00
52-week low$33.68
Market cap2.06B
Volume352.99K
Average volume529.86K
P/E ratio28.72
Forward P/E21.16
EPS1.89
Dividend yield0.00%

Market context

Why it moved

GSHD shares pulled back from the prior session's strong rally of over 6%, as profit-taking set in following the stock's significant surge, despite a recent JPMorgan analyst price target upgrade from $52 to $72 and an upcoming earnings report that analysts expect to be roughly in line with estimates.

Yahoo FinanceMarketbeatYahoo FinanceYahoo FinanceInstagram

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026Goosehead Insurance closed down 1.61% as investors position ahead of its Q2 2026 earnings report scheduled for July 22 after market close, with the stock trading well below the consensus analyst price target of $66.91. Mixed analyst sentiment — including a recent UBS buy rating with a $70 target and Royal Bank of Canada's more cautious sector perform at $55 — reflects divided views heading into earnings, where consensus calls for $0.49 EPS on ~$103M in revenue. Broader financial sector headwinds, including a tech-driven market selloff and geopolitical uncertainty tied to U.S.-Iran tensions, added to the pressure on GSHD shares.

-1.6132

July 16, 2026Goosehead Insurance surged nearly 7%, closing well above its previous close of $51.65 on above-average volume of over 750,000 shares, ahead of its Q2 2026 earnings report scheduled for July 22. Investor anticipation is building around the results, with UBS recently raising its price target to $70 (Buy) and Keefe, Bruyette & Woods lifting theirs to $80 (Outperform). The move also coincided with broad financial sector strength, with the XLF financial ETF near 52-week highs amid strong Wall Street bank earnings results and a favorable CPI print supporting rate-cut hopes.

6.8151

July 15, 2026Goosehead Insurance gained nearly 3% as investors positioned ahead of its Q2 2026 earnings report, scheduled for after market close on July 22. The company announced the earnings date today, with a conference call at 4:30 PM ET to follow. Analyst sentiment remains mixed — UBS raised its price target to $70 with a Buy rating, Royal Bank of Canada lifted its target to $55 with a Sector Perform, and the consensus sits at Hold with a $66.91 target, well above current levels, suggesting potential upside if Q2 results beat the expected $0.4855 EPS on $103.3 million in revenue.

2.6839

July 15, 2026Goosehead Insurance tumbled sharply, sharply underperforming the broader financial sector (XLF essentially flat) and S&P 500, which edged modestly higher on a cooler-than-expected CPI print. The sell-off came despite a pair of analyst price target upgrades — JPMorgan raised its target to $60 (Neutral) and RBC Capital lifted to $55 (Sector Perform) — and follows a material 8-K filing revealing a revised stockholders agreement that lowers Pre-IPO holder consent thresholds for ownership, asset deals, and equity issuances, raising governance concerns among investors. The stock's decline also coincides with broader insurance sector headwinds, with Q2 earnings for the group expected to show a year-over-year decline, even as Goosehead's Q1 results beat on EPS but missed significantly on revenue.

-8.3288

July 14, 2026Goosehead Insurance gained nearly 2.5% on Monday as multiple analyst price target upgrades provided a tailwind — JP Morgan raised its target from $55 to $60 (Neutral) and RBC Capital lifted its target from $52 to $55 (Sector Perform) — while Cantor Fitzgerald holds a more bullish $76 target with an Overweight rating. The stock's advance came despite a choppy broader market session pressured by U.S.-Iran tensions and oil price spikes, suggesting the analyst attention helped insulate shares. Investor focus remains on whether Goosehead can close the gap to the consensus fair value of ~$65–$66, given its recent sharp rebound from 52-week lows and continued momentum around its technology-driven sales culture and franchise growth strategy.

2.4841

July 10, 2026Goosehead Insurance edged higher after closing up modestly, recovering from a sharp selloff the prior session that saw shares fall roughly 5-7%. Investor focus remains on a wave of analyst activity: Cantor Fitzgerald raised its price target to $76 (overweight) and UBS lifted its target to $70 (buy), while the consensus sits at $66.18 with a Hold rating overall. Adding to the narrative, Goosehead was named to Selling Power's '60 Best Companies to Sell For 2026' list, and valuation debates persist — with some models pointing to ~19-23% undervaluation against intrinsic value estimates, though a lofty P/E of ~41x relative to insurance peers warrants caution.

1.0952

July 9, 2026Goosehead Insurance tumbled sharply, closing down nearly 7% on notably elevated volume — roughly double its average — as surging oil prices and renewed U.S.-Iran military exchanges reignited inflation fears and lifted Treasury yields, pressuring rate-sensitive financial stocks broadly. The sell-off came despite a constructive analyst backdrop, with both Cantor Fitzgerald and UBS raising their price targets to $76 and $70, respectively, on the same day, citing the company's strong Q1 earnings beat ($0.37 EPS vs. $0.20 consensus) and 23% revenue growth year-over-year.

-6.9244

July 9, 2026Goosehead Insurance gained over 2% on above-average volume — more than double its typical daily turnover — as UBS analyst Brian Meredith raised his price target from $67 to $70 while maintaining a Buy rating, citing continued confidence in the company's growth outlook. The move also aligns with a Simply Wall St. analysis estimating GSHD trades at a 22.6% discount to fair value, with earnings projected to grow 21.7% annually over three years. The gains came despite a broader risk-off session driven by escalating U.S.-Iran tensions and surging oil prices, suggesting GSHD outperformed the wider financial sector.

2.3381

MarketBeat · July 17, 2026Goosehead Insurance (NASDAQ:GSHD) Receives Consensus Rating of "Hold" from AnalystsMarketBeat · July 16, 2026Goosehead Insurance (NASDAQ:GSHD) Stock Price Up 7.5% - Still a Buy?Stock Titan · July 13, 2026Goosehead Insurance (NASDAQ: GSHD) revises Pre-IPO holder control and board rightsMoomoo · July 13, 2026RBC Capital Maintains Goosehead Insurance(GSHD.US) With Hold Rating, Raises Target Price to $55marketscreener.com · July 13, 2026RBC Capital Adjusts Price Target on Goosehead Insurance to $55 From $52, Maintains Sector Perform RatingPluang · July 10, 2026Goosehead Insurance named one of Selling Power's 60 Best Companies to Sell For 2026Moomoo · July 9, 2026Cantor Fitzgerald Maintains Goosehead Insurance(GSHD.US) With Buy Rating, Raises Target Price to $76Simply Wall Street · June 25, 2026Can Goosehead Insurance’s New AI-Focused CTO Redefine Its Moat in Insurance Distribution (GSHD)?
Benzinga · July 13, 2026JP Morgan Maintains Neutral on Goosehead Insurance, Raises Price Target to $60
Benzinga · July 13, 2026RBC Capital Maintains Sector Perform on Goosehead Insurance, Raises Price Target to $55
Mt Newswire · July 13, 2026RBC Capital Adjusts Price Target on Goosehead Insurance to $55 From $52, Maintains Sector Perform Rating
Benzinga · July 9, 2026Cantor Fitzgerald Maintains Overweight on Goosehead Insurance, Raises Price Target to $76
Benzinga · July 8, 2026UBS Maintains Buy on Goosehead Insurance, Raises Price Target to $70
Mt Newswire · July 8, 2026UBS Adjusts Price Target on Goosehead Insurance to $70 From $67, Maintains Buy Rating
Benzinga · June 9, 2026UBS Maintains Buy on Goosehead Insurance, Lowers Price Target to $67
Mt Newswire · June 9, 2026UBS Adjusts Price Target on Goosehead Insurance to $67 From $85, Maintains Buy Rating

Peers

S&P 500SPX · $7,457.69-1.01%Marsh & McLennan Companies, Inc.MRSH · $182.18+0.02%Aon plcAON · $367.21-0.39%Arthur J. Gallagher & Co.AJG · $253.90-0.79%Willis Towers Watson Public Limited CompanyWTW · $293.43-0.31%Brown & Brown, Inc.BRO · $69.35-0.13%Lemonade, Inc.LMND · $67.18+4.04%Essent Group Ltd.ESNT · $66.71+0.65%Enact Holdings Inc.ACT · $46.52-0.06%Erie Indemnity CompanyERIE · $227.31+0.61%TWFG, Inc. Common StockTWFG · $26.35-0.68%Skyward Specialty Insurance Group, Inc.SKWD · $59.21+1.27%